MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202647127588 A) filed by Silklyfe Inc. on October 26, 2026, for Silk Peptides Oral Formulations And Methods Of Their Use.
Inventors include Santos, Mike; and Koppel, Charles.
The application for the patent was published on October 30, 2026, under issue no. 44/2026.
Abstract: A composition comprising fragments of silk fibroin peptides for use in the treatment of a disorder or condition associated with a digestive, pulmonary, or skin disorder. The composition may be also used prophylactically. Several embodiments are proposed in which the composition may be orally administered in a form which prevents unintended degradation of the composition until it reaches a specific point of interest. The composition can be modified to include additional agents for use in the treatment of various disorders of the digestive system, the pulmonary system, or the skin as described herein.
Disclaimer: Curated by HT Syndication.
